Healthcare Services Company
Takeda Pharmaceutical has acquired 17 companies, including 5 in the last 5 years. A total of 6 acquisitions came from private equity firms. It has also divested 6 assets.
Takeda Pharmaceutical’s largest acquisition to date was in 2018, when it acquired Shire for $67.7B. It’s largest disclosed sale occurred in 2015, when it sold Takeda Pharmaceutical Company - Core Respiratory Business to AstraZeneca for $575M. Takeda Pharmaceutical has acquired in 6 different US states, and 5 countries. The Company’s most targeted sectors include life science (93%) and healthcare services (8%).
Join Mergr and gain access to Takeda Pharmaceutical’s M&A summary, the M&A summaries of companies just like it, as well as recent M&A activity in the healthcare services sector.
M&A Summary
-
M&A Total Activity19
- M&A Buy Activity13
- M&A Sell Activity6
- Total Sectors Invested 2
- Total Countries Invested 5
- M&A Buy/Sell Connections 13
- M&A Advisors 7
Unlimited Searches
